Expression of beta-defensin 4 is increased in human gastritis

European Journal of Clinical Investigation

Volumn 39, Issue 2, 2009, Pages 126-138

  Otte, J M ^a,b   Neumann, H M ^a,b   Brand, S ^c   Schrader, H ^a,b   Schmidt, W E ^a,b   Schmitz, F ^a,b  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antimicrobial peptides; Gastritis; Helicobacter pylori; Human defensin 4; Toll like receptors

Indexed keywords

BETA DEFENSIN 4; CAGA PROTEIN; PATTERN RECOGNITION RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; PROTON PUMP INHIBITOR; RIBONUCLEASE; RIBONUCLEASE 7; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; GASTRITIS; GENE CONTROL; GENE SEQUENCE; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH EPITHELIUM; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CASE-CONTROL STUDIES; FEMALE; GASTRIC MUCOSA; GASTRITIS; GENE EXPRESSION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RIBONUCLEASES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 58649100920     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.02071.x     Document Type: Article

References (46)

1. Parsonnet J. Helicobacter pylori: the size of the problem. Gut 1998 43 (Suppl. 1 6 9.
2. Weck MN, Brenner H. Association of Helicobacter pylori infection with chronic atrophic gastritis: meta-analyses according to type of disease definition. Int J Cancer 2008 123 : 874 81.
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991 325 : 1127 31.
4. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994 330 : 1267 71.
5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001 345 : 784 9.
6. Kuipers EJ. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1997 11 (Suppl. 1 71 88.
7. Kandulski A, Selgrad M, Malfertheiner P. Helicobacter pylori infection: a clinical overview. Dig Liver Dis 2008 40 (8 619 26.
8. Crabtree JE, Wyatt JI, Trejdosieics LK, Peichl P, Nichols PH, Ramsay N et al. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 1994 47 : 945 50.
9. Hida N, Shimoyama T Jr., Neville P, Dixon MF, Axon AT, Shimoyama TSr. et al. Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol 1999 52 : 658 64.
10. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000 54 : 615 40.
11. Bliss CM Jr., Golenbock DT, Keates S, Linevsky JK, Kelly CP. Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes. Infect Immun 1998 66 : 5357 63.
12. Innocenti M, Svennerholm AM, Quiding-Jarbrink M. Helicobacter pylori lipopolysaccharides preferentially induce CXC chemokine production in human monocytes. Infect Immun 2001 69 : 3800 8.
13. Wehkamp J, Schmid M, Stange EF. Defensins and other antimicrobial peptides in inflammatory bowel disease. Curr Opin Gastroenterol 2007 23 : 370 8.
14. Soylu OB, Ozturk Y, Ozer E. Alpha-defensin expression in the gastric tissue of children with Helicobacter pylori-associated chronic gastritis: an immunohistochemical study. J Pediatr Gastroenterol Nutr 2008 46 : 474 7.
15. Wehkamp J, Schmidt K, Herrlinger KR, Baxmann S, Behling S, Wohlschlager C et al. Defensin pattern in chronic gastritis: HBD-2 is differentially expressed with respect to Helicobacter pylori status. J Clin Pathol 2003 56 : 352 7.
16. Hase K, Murakami M, Iimura M, Cole SP, Horibe Y, Ohtake T et al. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 2003 125 : 1613 25.
17. Ohara T, Morishita T, Suzuki H, Masaoka T, Nagata H, Hibi T. Pathophysiological role of human beta-defensins 2 in gastric mucosa. Int J Mol Med 2004 14 : 1023 7.
18. Wada A, Mori N, Oishi K, Hojo H, Nakahara Y, Hamanaka Y et al. Induction of human beta-defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island. Biochem Biophys Res Commun 1999 263 : 770 4.
19. O'Neil DA, Cole SP, Martin-Porter E, Housley MP, Liu L, Ganz T et al. Regulation of human ß-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect Immun 2000 68 : 5412 5.
20. Hamanaka Y, Nakashima M, Wada A, Ito M, Kurazono H, Hojo H et al. Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut 2001 49 : 481 7.
21. Wada A, Ogushi K, Kimura T, Hojo H, Mori N, Suzuki S et al. Helicobacter pylori-mediated transcriptional regulation of the human β-defensin 2 gene requires NF-κB. Cell Microbiol 2001 3 : 115 23.
22. Kawauchi K, Yagihashi A, Tsuji N, Uehara N, Furuya D, Kobayashi D et al. Human beta-defensin-3 induction in H. pylori-infected gastric mucosal tissues. World J Gastroenterol 2006 12 : 5793 7.
23. Fahlgren A, Hammarstrom S, Danielsson A, Hammarstrom ML. Beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clin Exp Immunol 2004 137 : 379 85.
24. Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 2001 10 : 1819 21.
25. Harder J, Schroder JM. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 2002 277 : 46779 84.
26. Kiehne K, Fincke A, Brunke G, Lange T, Fölsch UR, Herzig KH. Antimicrobial peptides in chronic anal fistula epithelium. Scand J Gastroenterol 2007 42 : 1063 9.
27. Brandt S, Kwok T, Hartig R, König W, Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A 2005 102 : 9300 5.
28. Smith MF Jr., Mitchell A, Li G, Ding S, Fitzmaurice AM, Ryan K et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 2003 278 : 32552 60.
29. Kawahara T, Kuwano Y, Teshima-Kondo S, Kawai T, Nikawa T, Kishi K et al. Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. J Med Invest 2001 48 : 190.
30. Ishihara S, Rumi MA, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N et al. Essential role of MD-2 in TLR4-dependent signalling during Helicobacter pylori-associated gastritis. J Immunol 2004 173 : 1406 16.
31. Rad R, Brenner L, Krug A, Voland P, Mages J, Lang R et al. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology 2007 133 : 150 63.
32. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004 5 : 1166 74.
33. Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut 1999 45 : 804 11.
34. Chang YH, Wang L, Lee MS, Cheng CW, Wu CY, Shiau MY. Genotypic characterization of Helicobacter pylori cagA and vacA from biopsy specimens of patients with gastroduodenal diseases. Mt Sinai J Med 2006 73 : 622 6.
35. Su B, Ceponis PJ, Lebel S, Huynh H, Sherman PM. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun 2003 71 : 3496 502.
36. Mandell L, Moran AP, Cocchiarella A, Houghton J, Taylor N, Fox JG et al. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect Immun 2004 72 : 6446 54.
37. Maeda S, Akanuma M, Mitsuno Y, Hirata Y, Ogura K, Yoshida H et al. Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells. J Biol Chem 2001 276 : 44856 64.
38. Backhed F, Rokbi B, Torstensson E, Zhao Y, Nilsson C, Seguin D et al. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J Infect Dis 2003 187 : 829 36.
39. Hirata Y, Ohmae T, Shibata W, Maeda S, Ogura K, Yoshida H et al. MyD88 and TNF receptor-associated factor 6 are critical signal transducers in Helicobacter pylori-infected human epithelial cells. J Immunol 2006 176 : 3796 803.
40. Keates S, Keates AC, Warny M, Peek RM Jr., Murray PG, Kelly CP. Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori. J Immunol 1999 163 : 5552 9.
41. Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM Jr. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 2004 189 : 1914 20.
42. Isomoto H, Mizuta Y, Miyazaki M, Takeshima F, Omagari K, Murase K et al. Implication of NF-kappaB in Helicobacter pylori-associated gastritis. Am J Gastroenterol 2000 95 : 2768 76.
43. Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S et al. Mucoid Pseudomonas aeruginosa, TNF-α, and IL-1β but not IL-6, induce human β-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000 22 : 714 21.
44. Liu L, Wang L, Jia HP, Zhao C, Heng HH, Schutte BC et al. Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation. Gene 1998 222 : 237 44.
45. Gambichler T, Skrygan M, Tomi NS, Altmeyer P, Kreuter A. Changes of antimicrobial peptide mRNA expression in atopic eczema following phototherapy. Br J Dermatol 2006 155 : 1275 8.
46. Gambichler T, Skrygan M, Appelhans C, Tomi NS, Reinacher-Schick A, Altmeyer P et al. Expression of human beta-defensins in patients with mycosis fungoides. Arch Dermatol Res 2007 299 : 221 4.